Navigation Links
Aura Nd Yag Photodisruptor

ProductsAura Nd Yag Photodisruptor
Company Lumenis Inc.
Item Aura Nd Yag Photodisruptor
Features Designed to be safe and easy to use. Advanced photodisruptor design. Precision optics and targeting. Point and shoot ease. Variable offset. Console control on table top.
Description Aura's precision optics and targeting make treatment quick and effective for superior patient care. The 16 degree cone angle, adjustable offset and variable pulse burst mode allow you to perform capsulotomies on the most modern IOLs without damage or pitting. Aura's laser design and precision optics ensure low energy plasma formation with less trauma to the eye.
Info Lumenis Inc.
Customer Service: 877-lumenis

Related medicine products :

1. Tango SLT and Photodisruptor Combination Laser
2. Super Q - Nd: YAG Laser Photodisruptor
3. Ultra Q Nd: YAG Photodisruptor
4. Ultra Q, Nd: YAG Photodisruptor
5. Ultra Q - SLT-upgradeable, Nd: YAG Photodisruptor
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products:
(Date:5/16/2008)...y announces appointment of Nomura Code Securities ... sole broker, NEW YORK, May 16 /PRNewswire-FirstC...l Investments, Inc. (Amex: MGT ) (the "Company"),...uter-Aided Detection (CAD) and,image analysis soft...nosis,of disease, today announced the appointment ...
(Date:5/16/2008)...ai researchers may have unlocked the key to better...the human brain. Researchers have just published t...binoid Receptor Signaling Network that Triggers Ne... May 16th, 2008. , The research findings give u...er understand the role addictive drugs have on the...
(Date:5/16/2008)...tion Health CEO: ,We need to get the system out of...tCall/ -- Internet visionary,turned e-health entre... in,public policy, technology and consumerism in h...snow globe," simultaneously creating disruption an...ican health care., The America Online co-founder,...
(Date:5/16/2008)...uld allow physicians to determine much sooner if t...althDay News) -- A simple blood test to check leve...e accurately assess how well treatments are workin...g to a Georgetown University Medical Center study....onths, to determine if a particular cancer treatme...
Breaking Medicine News(10 mins):Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 2Health News:Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser 3Health News:'Case' in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution 2Health News:'Case' in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution 3Health News:'Case' in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution 4Health News:Blood Test Helps Docs Assess Breast Cancer Treatment 2
...est and most troublesome disease affecting million... from the usual symptoms of the disease but they a... knowledge that asthmatics are warned to stay away...matory drugs. What happens when they take aspirin?...
...te instances we see couples who are HIV sero disco...sband is HIV –1 positive and the wife is negative ...arises because sexual intercourse carries a 1 in 5...artner and through her to the fetus. Sperm washing...
... to be afflicted by the deadly chronic myeloid leu...some good news. One of the deadliest forms of le...ousands across the globe. Chronic myeloid leuke...till continues to be one. But there's good news. ...
...practice of Acupuncture along with commonly used m...ling side effects of chemotherapy for breast cance...f Health (NIH) are to be believed. According to ...sociate at NIH, electro-acupuncture was more effec...
Other Medicine News:Health News:Sperm washing helps couples – Breakthrough in focu 2
(Date:5/15/2008)...RNewswire-FirstCall/ -- Cytopia Limited,(ASX: CYT)...g oral,presentation on CYT997 at the 2008 Annual M...y (ASCO) will be accessible to the public via ASCO...rsday 15 May (US EDT)., The oral presentation, en...toxic and vascular disrupting agent, in patients w...
(Date:5/15/2008)...wswire-FirstCall/ -- Sanofi-aventis,(EURONEXT: SAN... the,landmark ATHENA study showed Multaq(R) (drone...patients with atrial fibrillation or atrial flutte...ations or death from any,cause by a statistically ...primary endpoint. The ATHENA results will be prese...
(Date:5/15/2008)...CenterWatch, a publishing and,information services...,trials, finds that investigative sites are requir... systems. More than 75% of respondents to a recent...rained on three or more,EDC systems. In addition, ...ir EDC training had improved., State of the Clini...
(Date:5/15/2008)...Plan Positions Blue Cross Blue Shield of Mich...t from HealthLeaders-InterS...althLeaders-InterStudy, the,leading provider of ma...e,economy continues to stagnate in Michigan, Blue ...ipped of all of its competitors to weather the,eco...
Breaking Medicine Technology:Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Access Highlighted in Recent BusinessWeek Article 498 1Access Highlighted in Recent BusinessWeek Article 498 2Prescription labels geared toward pharmacies not patients 982 1Prescription labels geared toward pharmacies not patients 982 2Scientists fear rare dolphin driven to extinction by human activities 345 1Scientists fear rare dolphin driven to extinction by human activities 345 2IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 1IVCC launches groundbreaking insecticide projects with Bayer and Syngenta 978 2
...LONA, SPAIN and SEATTLE, WA -- (MARKET WIRE) -- Ju...AQ: TGEN) today is,reporting data from the dose es...udy of tgAAC94 in patients with inflammatory,arthr... the,University of Washington School of Medicine, ...dish Medical Center, practicing,physician with Sea...
...DGE, Mass.--(BUSINESS WIRE)--Jun 14, 2007 - Combin... the presentation of,additional data related to it...and CRx-139, at the European League Against,Rheuma...ng, June,13-16, 2007 in Barcelona, Spain., CRx-102...and Chondrocyte,Inflammatory Mediators by CRx-102,...
Other Medicine Technology:Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 2Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 3Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 4Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 5Targeted Genetics Reports Inflammatory Arthritis Clinical Data at,European Rheumatology Conference 6Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4